Accéder au contenu
Merck

Pyridoxine hydrochloride treatment of carpal tunnel syndrome: a review.

Nutrition reviews (2004-04-22)
Elaine Aufiero, Todd P Stitik, Patrick M Foye, Boqing Chen
RÉSUMÉ

It has been hypothesized that idiopathic carpal tunnel syndrome (CTS) is a manifestation of vitamin B6 deficiency. Some claim that B6 supplementation can alleviate symptoms. Others argue that pain relief occurs because of vitamin B6's anti-nociceptive properties or because B6 supplementation addresses an unrecognized peripheral neuropathy. Few studies on CTS and B6 employed electrodiagnostic techniques in diagnosis, and few showed a correlation between symptoms and improved electrodiagnostic parameters with supplementation. Other studies failed to measure or estimate B6 levels. Nevertheless, it appears reasonable to recommend vitamin B6 supplementation to people with CTS. Some patients will improve symptomatically with low risks of toxicity in recommended doses.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Pyridoxine hydrochloride, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture
Sigma-Aldrich
Pyridoxine, ≥98%
Supelco
Pyridoxine Hydrochloride (B6), analytical standard
Supelco
Pyridoxine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Pyridoxine hydrochloride, ≥98% (HPLC)
USP
Pyridoxine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Pyridoxine hydrochloride, meets USP testing specifications
Pyridoxine hydrochloride, European Pharmacopoeia (EP) Reference Standard